Portal de investigación
Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Duraj T
- García-Romero N
- Carrión-Navarro J
- Madurga R
- Mendivil AO
- Garcia-Cañamaque L
- Ayuso-Sacido A
Grupos
Abstract
Glioblastoma (GBM) is the most aggressive primary brain tumor, with a median survival at diagnosis of 16-20 months. Metabolism represents a new attractive therapeutic target; however, due to high intratumoral heterogeneity, the application of metabolic drugs in GBM is challenging. We characterized the basal bioenergetic metabolism and antiproliferative potential of metformin (MF), dichloroacetate (DCA), sodium oxamate (SOD) and diazo-5-oxo-L-norleucine (DON) in three distinct glioma stem cells (GSCs) (GBM18, GBM27, GBM38), as well as U87MG. GBM27, a highly oxidative cell line, was the most resistant to all treatments, except DON. GBM18 and GBM38, Warburg-like GSCs, were sensitive to MF and DCA, respectively. Resistance to DON was not correlated with basal metabolic phenotypes. In combinatory experiments, radiomimetic bleomycin exhibited therapeutically relevant synergistic effects with MF, DCA and DON in GBM27 and DON in all other cell lines. MF and DCA shifted the metabolism of treated cells towards glycolysis or oxidation, respectively. DON consistently decreased total ATP production. Our study highlights the need for a better characterization of GBM from a metabolic perspective. Metabolic therapy should focus on both glycolytic and oxidative subpopulations of GSCs.
Datos de la publicación
- ISSN/ISSNe:
- 2073-4409, 2073-4409
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 33498369
- Factor de Impacto:
- 1,452 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Cells MDPI
Citas Recibidas en Web of Science: 51
Documentos
- No hay documentos
Filiaciones
Keywords
- energy metabolism, gene expression profiling, glioblastoma, glycolysis, oxidative phosphorylation, therapeutics
Proyectos y Estudios Clínicos
EVALUACIÓN DEL ÍNDICE DE PROLIFERACIÓN KI-67 COMO PREDICTOR DE RECIDIVA EN MENINGIOMAS CEREBRALES GRADO I DE LA OMS. COMPARACIÓN CON LA ESCALA DE RESECCIÓN QUIRÚRGICA DE SIMPSON.
Investigador Principal: LUIS RICARDO PRAT ACÍN
2013_0041_CRC_PRAT . FUNDACION MUTUA MADRILEÑA . 2013
ESTUDIO OBSERVACIONAL PROSPECTIVO ACERCA DEL MANEJO PERIOPERATORIO / PERIPROCEDIMIENTO DE LOS FÁRMACOS ANTITROMBÓTICOS EN EL “MUNDO REAL”: REGISTRO REQXAA.
Investigador Principal: RAQUEL FERRANDIS COMES
SEC-API-2019-01 . 2021
Cita
Duraj T,García N,Carrión J,Madurga R,Mendivil AO,PRAT R,Garcia L,Ayuso A. Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma. Cells. 2021. 10. (2):202. IF:7,666. (2).